ClinicalTrials.gg
Status unknownNCT06148909Updated Nov 28, 2023

Small Talk Intervention With MI for Smoking Cessation

An interventional study of Small Talk Motivational Interviewing in Smoking Cessation and Motivation, sponsored by The Hong Kong Polytechnic University. Status unknown at 1 site in Hong Kong. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Nov 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The goal of this pilot study is to examine the effectiveness of the STMI in promoting abstinence in unmotivated smokers. The main questions it aims to answer are:

  • Do unmotivated smokers treated with STMI exhibit higher abstinence rate than those in the control group?
  • Do unmotivated smokers treated with STMI show higher intention to quit than those in the control group?
  • Do unmotivated smokers treated with STMI show higher smoking reduction rates than those in the control group?
  • Do unmotivated smokers treated with STMI show lower level of depressive symptoms than those in the control group?
  • Do unmotivated smokers treated with STMI show higher adherence than those in the control group?
  • Does STMI show higher consent rates than those the control?
  • How does STMI affect the smoking behaviors in unmotivated smokers?

Participants will be randomized to (1) STMI or (2) control group for smoking cessation services via telephone, and then be invited to join a semi-structured interview.

Read the detailed description

Two RAs with at least 1 year of experience in counseling or related work will be hired to deliver the intervention. The same RA will deliver the eight-session intervention weekly via telephone to the same participant within 2 months. The intervention contains eight sessions which is similar to that in YQL. Interventions will be delivered via telephone because YQL also used the same delivery mode to successfully contact and assist a considerable number of smokers to quit . Based on our team's experience in YQL, each session will last from 30 minutes to 1 hour.

In the first to third sessions, the RA will engage in small talk with the participants for 30 minutes. The RA will talk to the participants on the proposed topics including the weather, activities the participant engaged in last week and at weekends, music, food, and other hobbies, all of which were recommended in previous literature as topics that interest most people and create curiosity and enjoyment rather than animosity. From the fourth session onwards, the RA will add 30 minutes of MI about smoking cessation after engaging in small talk. During MI delivery, the RA will use core MI skills, including open-ended questions, affirmation, reflective listening, and summary, elicit-provide-elicit, evoking change talk, and roll with resistance to move the participants from engaging (first process of MI) to planning (last process of MI), as in YQL and other smoking cessation projects that use MI. The RA will aim to go through the engaging process in the fourth session, focusing process in the fifth session, focusing and evoking in the sixth session, and evoking and planning in the seventh and eighth sessions. When transitioning from small talk to MI, some simple transitional sentences are suggested, such as: "We have been talking for quite a while since our contact at the first time. Actually, I am quite interested in understanding your smoking behaviors. Do you mind talking with me about that?" If the participants refuse, the RA will continue to deliver small talk and repeat asking in the next session if the participants can move to talk about smoking or not.

02

Conditions studied

  • Smoking Cessation
  • Motivation

Browse trials for

Keywords

  • Smoking Cessation
  • Motivational Interviewing
  • Small Talks
03

In context

Smoking Cessation

350 studies on the registry are indexed under Smoking Cessation; 145 are open to participants now.

This study's planned enrollment of 40 is below the median of 150 across 326 interventional studies indexed under Smoking Cessation.

Browse Smoking Cessation studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 676 studies on the registry; 254 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-25 years old
  • Have smoked any smoking products in the past 30 days
  • do not intend to quit in the coming 30 days
  • did not have a past-year quit attempt lasting for 24 hours or more
  • are not currently in any smoking cessation programs
  • are able to speak Cantonese and read Chinese

Exclusion criteria

Exclusion Criteria:

  • self-report having identified cognitive problems or psychosis, including schizophrenia, psychotic depression, and schizoaffective disorder will be excluded
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Small Talk Motivational Interviewing (STMI)

    during the 8 session of smoking cessation, the first three sessions will be used to do small talks with the participant. And then from the fourth session onwards, the RA will add 30 minutes of MI about smoking cessation after engaging in small talk.

    Other: Small Talk Motivational Interviewing

  • No intervention
    Control (only MI)

    Another two RA with at least one-year experience on counselling will be delivering the control group. Participant will receive MI for 30 minutes in each of the first three sessions and 1 hour in each of the remaining sessions. The control group will also receive the same duration and content of boosters as in the intervention group.

Interventions

  • OtherSmall Talk Motivational Interviewing

    Combining small talks and skills on Motivational Interviewing in the smoking cessation services

06

What researchers measure

Primary outcomes

  1. biochemically-validated abstinence rate

    participants will be invited to join a breath test at 6-month time point after they joined the study, to determine if they have quitted smoking or not

    Time frame: 6-month follow-up

Secondary outcomes

  1. Self-reported questionnaire

    Including self-reported quit rate, intention to quit, smoking reduction, depressive symptoms

    Time frame: 1-week, 1-, 3-, 6-, 9-, and 12-month follow-ups

07

Study locations

1 site
  • Katherine Lam
    Hong Kong, Hong Kong,China 0000, Hong Kong
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06148909
Responsible party
Sponsor
First posted
Nov 28, 2023
Start date
Dec 1, 2023 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Nov 28, 2023

Study contacts

Ka Wai Katherine Lam, Phd
Contact
kw-katherine.lam@polyu.edu.hk
27666420
Ka Wai Katherine Lam, Phd
principal investigator · the polytechnic university of hong kong

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion